View in EDS HTML Full Text PDF Full Text

Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review.

Saved in:
Bibliographic Details
Title: Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review.
Authors: Perrotta, Nicola1 (AUTHOR), Coluccia, Adriana1 (AUTHOR), Rossi, Francesca1 (AUTHOR), Amato, Giulia2 (AUTHOR) giulia.amato@uniroma1.it, Polito, Giacomo1 (AUTHOR)
Source: Cancer Medicine. Jul2026, Vol. 15 Issue 7, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.72129